Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Recently issued patent covers Berlex's new anticoagulants

Dec. 23, 1999

Selective, orally active factor Xa inhibitors designed by JT scientists

Dec. 22, 1999

Meiji Seika presents heterocyclic inhibitors of platelet aggregation

Dec. 22, 1999

Orally active antiplatelet agents derived from isoquinolone leads at Lilly

Dec. 21, 1999

Hungarian team describes novel orally active antithrombotic agents

Dec. 21, 1999

Efficacy and mechanism of action of DX-9065a in experimental DIC in rats

Dec. 21, 1999

New antiplatelet pyridazinones presented by Chinese university investigators

Dec. 20, 1999

Emisphere Technologies to begin phase III oral heparin program

Dec. 17, 1999

Corvas and Schering-Plough extend oral anticoagulant collaboration

Dec. 17, 1999

Antiplatelet agents synthesized at Chinese university

Dec. 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....